Abstract | OBJECTIVE: To testify whether absolute neutrophil count (ANC) response to preimmunosuppressive- therapy (pre-IST) granulocyte-stimulating factor ( G-CSF) treatment could predict early response to IST in severe aplastic anemia (SAA). METHODS: Clinical data and hematologic response of 125 SAA patients treated with antithymocyte globulin (r-ATG) combined with cyclosporine were retrospectively analyzed. Correlation of ANC response to pre-IST G-CSF treatment and early response to IST were statistically analyzed, and receiver operating characteristic (ROC) curve was used to estimate the value of increased ANC (∆ANC) in predicting early IST response. RESULTS: The hematologic response (HR) rate to IST in ANC reponded patients was significantly higher than non-responded group (3-month HR 49.0% vs 28.9%, P=0.023; 6-month HR 61.2% vs 40.8%, P=0.026). With ∆ANC≥0.5×10⁹/L as cutoff level, the best point to predict early IST response was 10 days after G-CSF (d 10). Response of ANC to pre-IST G-CSF treatment at d 10 was among the independent factors of predicting 3-month (P=0.004), but not for 6-month response to IST. The overall 5-year survival rate was 92.8% and 69.5% in ANC responded and non-responed groups, respectively (P=0.025). CONCLUSION: Responding to pre-IST G-CSF treatment reflected the residual bone marrow hematopoiesis, and could act as a convenient and practical predictor to early IST response as well as long-term survival in SAA.
|
Authors | Zhijie Wu, Wenrui Yang, Li Zhang, Liping Jing, Kang Zhou, Yang Li, Guangxin Peng, Lei Ye, Yuan Li, Jianping Li, Huihui Fan, Lin Song, Xin Zhao, Fengkui Zhang |
Journal | Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
(Zhonghua Xue Ye Xue Za Zhi)
Vol. 35
Issue 11
Pg. 974-9
(Nov 2014)
ISSN: 0253-2727 [Print] China |
PMID | 25417872
(Publication Type: Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Granulocyte Colony-Stimulating Factor
|
Topics |
- Anemia, Aplastic
(drug therapy)
- Granulocyte Colony-Stimulating Factor
(therapeutic use)
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Neutrophils
(drug effects)
|